Kaseta Michael — SEC insider filings
SEC reporting owner CIK 1724346. 49 insider filings on record with FilingPulse; latest filed 2026-10-13.
Transaction summary — filings shown
Covers all 49 filings on record, filed 2020-12-01 to 2026-10-13. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): 4 legs across 3 filings — 28,627 shares, $132,307 total (shares × price as filed).
- Open-market sales (code S, non-derivative): 31 legs across 25 filings — 546,474 shares, $18,868,350 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 94.
- Largest priced transaction: sale of 133,789 shares @ $40.24 ($5,383,388) in Liquidia Corp, filed 2026-04-13.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Liquidia Corp (LQDA) | CFO and COO | 42 | 4 legs · 28,627 sh · $132,307 | 31 legs · 546,474 sh · $18,868,350 | 83 |
| HERON THERAPEUTICS, INC. /DE/ (HRTX) | Director | 4 | — | — | 7 |
| ALIMERA SCIENCES INC (ALIM) | Director | 3 | — | — | 4 |
Insider filings — Kaseta Michael
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-10-13 | 4 | Liquidia Corp (LQDA) | Option exercise (M): 5,828 · Option exercise (M): 7,049 · Sale (S): 18,938 @ $28.48 · Option exercise (M): 5,828 (derivative) @ $0 · Option exercise (M): 7,049 (derivative) @ $0 | EDGAR |
| 2026-07-14 | 4 | Liquidia Corp (LQDA) | Option exercise (M): 5,829 · Option exercise (M): 7,050 · Sale (S): 1,453 @ $71.39 · Sale (S): 18,977 @ $71.52 · Option exercise (M): 5,829 (derivative) @ $0 · Option exercise (M): 7,050 (derivative) @ $0 | EDGAR |
| 2026-04-16 | 4 | Liquidia Corp (LQDA) | Option exercise (M): 3,000 @ $2.79 · Sale (S): 3,000 @ $40 · Sale (S): 9,044 @ $40.14 · Option exercise (M): 86,971 @ $2.79 · Sale (S): 86,971 @ $40.14 · Sale (S): 43,375 @ $40.14 · +2 more | EDGAR |
| 2026-04-14 | 4 | Liquidia Corp (LQDA) | Option exercise (M): 23,821 @ $2.79 · Sale (S): 23,821 @ $40.14 · Option exercise (M): 5,828 · Option exercise (M): 7,050 · Sale (S): 18,958 @ $38.37 · Option exercise (M): 23,821 (derivative) @ $0 · +2 more | EDGAR |
| 2026-04-13 | 4 | Liquidia Corp (LQDA) | Option exercise (M): 19,042 @ $2.79 · Option exercise (M): 86,632 @ $2.79 · Option exercise (M): 18,115 @ $2.97 · Option exercise (M): 728 @ $2.54 · Option exercise (M): 9,272 @ $2.54 · Sale (S): 133,789 @ $40.24 · +5 more | EDGAR |
| 2026-03-03 | 4 | Liquidia Corp (LQDA) | Option exercise (M): 2,344 · Sale (S): 1,165 @ $30.58 · Option exercise (M): 2,344 (derivative) @ $0 | EDGAR |
| 2026-02-03 | 4 | HERON THERAPEUTICS, INC. /DE/ (HRTX) | Grant/award (A): 53,960 @ $0 | EDGAR |
| 2026-01-21 | 4 | Liquidia Corp (LQDA) | Grant/award (A): 59,320 @ $0 · Grant/award (A): 88,980 (derivative) @ $0 | EDGAR |
| 2026-01-13 | 4 | Liquidia Corp (LQDA) | Option exercise (M): 5,828 · Option exercise (M): 28,200 · Sale (S): 36,932 @ $37.43 · Option exercise (M): 5,828 (derivative) @ $0 · Option exercise (M): 28,200 (derivative) @ $0 | EDGAR |
| 2025-12-02 | 4 | Liquidia Corp (LQDA) | Option exercise (M): 2,343 · Sale (S): 1,166 @ $32.19 · Option exercise (M): 2,343 (derivative) @ $0 | EDGAR |
| 2025-10-15 | 4 | Liquidia Corp (LQDA) | Option exercise (M): 5,828 · Sale (S): 11,630 @ $23.41 · Option exercise (M): 5,828 (derivative) @ $0 | EDGAR |
| 2025-09-03 | 4 | Liquidia Corp (LQDA) | Option exercise (M): 2,344 · Sale (S): 1,148 @ $29.05 · Option exercise (M): 2,344 (derivative) @ $0 | EDGAR |
| 2025-08-19 | 4 | Liquidia Corp (LQDA) | Sale (S): 20,000 @ $26.18 | EDGAR |
| 2025-08-07 | 4 | Liquidia Corp (LQDA) | Sale (S): 30,000 @ $20.00 | EDGAR |
| 2025-07-15 | 4 | Liquidia Corp (LQDA) | Option exercise (M): 5,828 · Sale (S): 11,580 @ $14.28 · Option exercise (M): 5,828 (derivative) @ $0 | EDGAR |
| 2025-06-05 | 4 | Liquidia Corp (LQDA) | Option exercise (M): 29,141 · Sale (S): 14,777 @ $16.97 · Option exercise (M): 29,141 (derivative) @ $0 | EDGAR |
| 2025-06-03 | 4 | Liquidia Corp (LQDA) | Option exercise (M): 2,344 · Sale (S): 859 @ $16.74 · Option exercise (M): 2,344 (derivative) @ $0 | EDGAR |
| 2025-04-16 | 4 | Liquidia Corp (LQDA) | Sale (S): 8,283 @ $13.57 | EDGAR |
| 2025-03-04 | 4 | Liquidia Corp (LQDA) | Option exercise (M): 2,344 · Sale (S): 874 @ $15.45 · Option exercise (M): 2,344 (derivative) @ $0 | EDGAR |
| 2025-02-04 | 4/A | HERON THERAPEUTICS, INC. /DE/ (HRTX) | Grant/award (A): 17,950 @ $0 · Grant/award (A): 35,900 (derivative) @ $0 | EDGAR |
| 2025-02-03 | 4 | HERON THERAPEUTICS, INC. /DE/ (HRTX) | Grant/award (A): 17,950 @ $0 · Grant/award (A): 35,900 (derivative) @ $1.73 | EDGAR |
| 2025-01-14 | 4 | Liquidia Corp (LQDA) | Grant/award (A): 112,797 @ $0 · Sale (S): 23,370 @ $11.78 · Grant/award (A): 112,797 (derivative) @ $0 | EDGAR |
| 2024-12-03 | 4 | Liquidia Corp (LQDA) | Option exercise (M): 2,343 · Sale (S): 1,091 @ $11.51 · Option exercise (M): 2,343 (derivative) @ $0 | EDGAR |
| 2024-11-06 | 4 | HERON THERAPEUTICS, INC. /DE/ (HRTX) | Grant/award (A): 37,879 · Grant/award (A): 227,272 (derivative) @ $1.78 | EDGAR |
| 2024-10-15 | 4 | Liquidia Corp (LQDA) | Sale (S): 3,892 @ $11.11 | EDGAR |
| 2024-09-18 | 4 | ALIMERA SCIENCES INC (ALIM) | Disposition to issuer (D): 50,000 (derivative) · Disposition to issuer (D): 1,825 (derivative) | EDGAR |
| 2024-09-04 | 4 | Liquidia Corp (LQDA) | Option exercise (M): 2,344 · Sale (S): 1,079 @ $9.50 · Option exercise (M): 2,344 (derivative) @ $0 | EDGAR |
| 2024-07-15 | 4 | Liquidia Corp (LQDA) | Sale (S): 3,906 @ $12.53 | EDGAR |
| 2024-06-04 | 4 | Liquidia Corp (LQDA) | Option exercise (M): 2,344 · Sale (S): 1,094 @ $14.55 · Option exercise (M): 2,344 (derivative) @ $0 | EDGAR |
| 2024-04-16 | 4 | Liquidia Corp (LQDA) | Sale (S): 3,136 @ $14.58 | EDGAR |
| 2024-03-19 | 4 | Liquidia Corp (LQDA) | Option exercise (M): 2,344 · Sale (S): 851 @ $15.82 · Sale (S): 11,315 @ $15.82 · Option exercise (M): 2,344 (derivative) @ $0 | EDGAR |
| 2024-01-16 | 4 | Liquidia Corp (LQDA) | Grant/award (A): 93,250 @ $0 · Grant/award (A): 50,000 @ $0 · Grant/award (A): 93,250 (derivative) @ $0 | EDGAR |
| 2023-12-05 | 4 | Liquidia Corp (LQDA) | Option exercise (M): 2,343 · Option exercise (M): 2,343 (derivative) @ $0 | EDGAR |
| 2023-10-04 | 4 | ALIMERA SCIENCES INC (ALIM) | Grant/award (A): 50,000 (derivative) @ $0 | EDGAR |
| 2023-09-05 | 4 | Liquidia Corp (LQDA) | Option exercise (M): 2,344 · Option exercise (M): 2,344 (derivative) @ $0 | EDGAR |
| 2023-06-02 | 4 | Liquidia Corp (LQDA) | Option exercise (M): 2,344 · Option exercise (M): 2,344 (derivative) @ $0 | EDGAR |
| 2023-04-10 | 4/A | Liquidia Corp (LQDA) | Grant/award (A): 1,927 @ $4.90 | EDGAR |
| 2023-03-28 | 4 | ALIMERA SCIENCES INC (ALIM) | Grant/award (A): 1,825 (derivative) @ $0 | EDGAR |
| 2023-03-02 | 4 | Liquidia Corp (LQDA) | Option exercise (M): 9,375 · Option exercise (M): 9,375 (derivative) @ $0 | EDGAR |
| 2023-01-13 | 4 | Liquidia Corp (LQDA) | Grant/award (A): 124,667 @ $0 · Grant/award (A): 159,829 (derivative) @ $0 | EDGAR |
| 2022-09-14 | 4 | Liquidia Corp (LQDA) | Purchase (P): 8,000 @ $5.99 | EDGAR |
| 2022-09-01 | 4 | Liquidia Corp (LQDA) | Purchase (P): 1,927 @ $4.90 | EDGAR |
| 2022-08-01 | 4 | Liquidia Corp (LQDA) | Grant/award (A): 150,000 (derivative) @ $0 | EDGAR |
| 2022-06-01 | 4 | Liquidia Corp (LQDA) | Purchase (P): 13,639 @ $4.01 · Purchase (P): 5,061 @ $4 | EDGAR |
| 2022-01-19 | 4 | Liquidia Corp (LQDA) | Grant/award (A): 37,500 (derivative) @ $0 · Grant/award (A): 75,000 (derivative) @ $0 | EDGAR |
| 2021-11-12 | 4 | Liquidia Corp (LQDA) | Option exercise (M): 9,250 · Grant/award (A): 9,250 (derivative) @ $0 | EDGAR |
| 2021-07-23 | 4 | Liquidia Corp (LQDA) | Grant/award (A): 10,000 (derivative) @ $0 | EDGAR |
| 2021-01-20 | 4 | Liquidia Corp (LQDA) | Grant/award (A): 18,500 (derivative) @ $0 · Grant/award (A): 9,250 (derivative) @ $0 | EDGAR |
| 2020-12-01 | 4 | Liquidia Corp (LQDA) | Grant/award (A): 230,000 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2020-11-20 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1724346 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs